On the other hand, when HRP2 was knocked down in MM.1S cells, MM cells became more resistant to bortezomib treatment because the apoptotic ratio of MM cells was decreased significantly at a dose-dependent manner (Figure 5C), and the alterations were significant (Figure 5D). The gene discussed is HDGFL2; the disease is Miyoshi myopathy.